Screener
Cytokinetics CYTK Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Cytokinetics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338217
FAQ
- What is Cytokinetics's retained earnings?
- Cytokinetics (CYTK) reported retained earnings of -$3.89B in Q2 2026.
- How has Cytokinetics's retained earnings changed year-over-year?
- Cytokinetics's retained earnings decreased by 29.8% year-over-year, from -$3B to -$3.89B.
- What is the long-term trend for Cytokinetics's retained earnings?
- Over 5 years (2020 to 2025), Cytokinetics's retained earnings has grown at a 28.6% compound annual growth rate (CAGR), from -$992.31M to -$3.49B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Cytokinetics's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude